Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein
- 31 December 1994
- Vol. 12 (14) , 1265-1269
- https://doi.org/10.1016/s0264-410x(94)80030-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccineVaccine, 1993
- The Children's Vaccine Initiative--Will It Work?The Journal of Infectious Diseases, 1993
- Induction and Enhancement of Immune Responses to Herpes Simplex Virus Type 2 in Humans by Use of a Recombinant Glycoprotein D VaccineThe Journal of Infectious Diseases, 1993
- Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus ChallengeThe Journal of Infectious Diseases, 1993
- Immunogenicity and Safety of Respiratory Syncytial Virus Subunit Vaccine in Seropositive Children 18-36 Months OldThe Journal of Infectious Diseases, 1993
- Safety and Immunogenicity of a Genetically Engineered Human Immunodeficiency Virus VaccineThe Journal of Infectious Diseases, 1991
- Existence of similar antigenic-sites on varicella-zoster virus gpI and gpIVVirus Research, 1989
- The Complete DNA Sequence of Varicella-Zoster VirusJournal of General Virology, 1986
- Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigensVirology, 1983
- Serological reactivity of some monoclonal antibodies to varicella-zoster virusArchiv für die gesamte Virusforschung, 1982